Concepedia

Evaluation of a Case Series of Patients With Palmoplantar Pustulosis in the United States

Megan H. Noe, Marilyn T. Wan, Arash Mostaghimi, Joel M. Gelfand, Ritesh Agnihothri, April W. Armstrong, Tina Bhutani, Alina G. Bridges, Nicholas Brownstone, Melissa Butt,

JAMA Dermatology · 2021 · 16 citations · 9 references

DOIFull text

Open access

Abstract

In this case series, PPP was associated with persistent symptoms, continued health care utilization, and a lack of consensus regarding effective treatments, emphasizing the unmet medical need in this population. Additional research is necessary to understand treatment response in these patients.

References

9

Tobacco Product Use Among Adults — United States, 2019

Monica E. Cornelius, Teresa W. Wang, Ahmed Jamal et al. · MMWR Morbidity and Mortality Weekly Report · 2020 · 978 citations · Full text

Epidemiology of psoriasis and palmoplantar pustulosis: a nationwide study using the Japanese national claims database

Kiyoshi Kubota, Yukari Kamijima, Tsugumichi Sato et al. · BMJ Open · 2015 · 301 citations · Full text

Secukinumab for moderate-to-severe palmoplantar pustular psoriasis: Results of the 2PRECISE study

Ulrich Mrowietz, H. Bachelez, A. David Burden et al. · Journal of the American Academy of Dermatology · 2019 · 134 citations · Full text

Palmoplantar psoriasis is associated with greater impairment of health-related quality of life compared with moderate to severe plaque psoriasis

Jina Chung, Kristina Callis Duffin, Junko Takeshita et al. · Journal of the American Academy of Dermatology · 2014 · 107 citations · Full text

, , +5

Efficacy and Safety of Guselkumab, an Anti–interleukin 23 Monoclonal Antibody, for Palmoplantar Pustulosis

Tadashi Terui, Satomi Kobayashi, Yukari Okubo et al. · JAMA Dermatology · 2018 · 104 citations · Full text